drugset / Trial / NCT01327326

Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain

NCT01327326

RandomizedCrossoverTriple-blindBasic science

Summary

The aim of this proposal is to characterize pain inhibition in healthy controls and Temporomandibular Disorder (TMD) patients with two models of endogenous pain modulation (off-set analgesia; conditioned pain modulation), and to investigate the function of the endogenous opioid system in these responses by using pharmacological blockade of the opioid receptor.

Timeline

Start
2011-12
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naltrexone Small molecule 50 mg Oral